News Releases

Congresses Continue to Support Aquaculture, Poultry and Swine Customers MADISON, N.J., November 24, 2015 –Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced the launch of its High Quality Congress website to support producers of aquaculture, poultry and swine. Since 2012, Merck Animal Health’s High Quality Congresses have served […]

Read more

Innovative Addition Further Strengthens CIV Product Line MADISON, N.J., November 20, 2015 – In response to the H3N2 canine influenza (CIV) outbreaks that impacted dogs in 241 states, Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Department of Agriculture (USDA) has issued a conditional product license […]

Read more

MADISON, N.J., November 12, 2015 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) and Harrisvaccines, Inc., today announced the companies have entered into an agreement under which Merck Animal Health will acquire Harrisvaccines, a privately-held company that develops, manufactures and sells vaccines for food production and companion animals. […]

Read more

Awards Presented to Four Young Scientists at the Global Foot-and-Mouth Disease Research Alliance 2015 Scientific Meeting MADISON, N.J., November 11, 2015 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) is proud to announce the presentation of awards to four young scientists at the Global Foot-and-Mouth Disease Research Alliance (GFRA) […]

Read more

Swine Producers Can Now Protect Piglets against Three Major Swine Diseases with Needle-free Intradermal Device MADISON, N.J., November 4, 2015 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced that the European Commission has approved PORCILIS® PCV ID, an intradermal vaccine against porcine circovirus type 2 (PCV2) […]

Read more

Merck Animal Health to Feature Product at European Buiatrics Congress in Rome MADISON, NEW JERSEY, October 15, 2015 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced FINADYNE® Transdermal (flunixin meglumine) pour-on solution can now be used to reduce pyrexia associated with acute mastitis. This claim adds […]

Read more

The company will provide 48 million doses of Avian Influenza Vaccine, RNA AMES, Iowa, October 14, 2015 – Iowa-based vaccine producer, Harrisvaccines, today announced it has been awarded a contract to provide Avian Influenza H5 vaccine to the United States Department of Agriculture’s Animal and Plant Health Inspection Service (USDA/APHIS). This action is being taken to […]

Read more

Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories KENILWORTH, N.J., Oct. 5, 2015 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell, a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine […]

Read more